Cargando…
The HLA-Cw6 Dilemma: Is It Really an Outcome Predictor in Psoriasis Patients under Biologic Therapy? A Monocentric Retrospective Analysis
HLA-Cw6 is one of the most strongly associated psoriasis susceptibility alleles. Data regarding correlation between HLA-Cw6 status and biologic treatment outcomes are divergent. The aim of our study in our cohort of psoriatic patients was to explore if the HLA-Cw6 status influences the response rate...
Autores principales: | Burlando, Martina, Russo, Roberto, Clapasson, Andrea, Carmisciano, Luca, Stecca, Anna, Cozzani, Emanuele, Parodi, Aurora |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600180/ https://www.ncbi.nlm.nih.gov/pubmed/32998429 http://dx.doi.org/10.3390/jcm9103140 |
Ejemplares similares
-
Psoriasis flares after COVID-19 vaccination: adherence to biologic therapy reduces psoriasis exacerbations: a case-control study
por: Burlando, Martina, et al.
Publicado: (2023) -
Psoriasis, Vitiligo, and Biologic Therapy: Case Report and Narrative Review
por: Burlando, Martina, et al.
Publicado: (2021) -
Treatment of moderate-to-severe plaque psoriasis with tildrakizumab in the real-life setting
por: Burlando, Martina, et al.
Publicado: (2021) -
“De Novo” Psoriasis and Relapse of Psoriasis Induced by Dupilumab: Three New Cases and Review of the Literature
por: Trave, Ilaria, et al.
Publicado: (2023) -
Dimethyl fumarate as a safe and effective therapy for recalcitrant psoriasis in comorbid patients
por: Burlando, Martina, et al.
Publicado: (2022)